PTHS 8-K 2026-10-01
Pelthos Therapeutics Inc. (PTHS) 8-K dated 2026-10-01 — accession 0001919246-26-000125.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Pelthos Therapeutics Inc. filed a 8-K on 2026-10-01. Accession 0001919246-26-000125.
This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Not investment advice. The PTHS SEC hub lists recent forms. The stock page is the research view.